Biomarkers in Neuropsychiatry

1. Biomarkers in medicine and psychiatry: an overview

2. Genetic biomarkers of psychiatric disorders



3. Neurophysiological biomarkers



4. Structural neuroimaging biomarkers in psychiatry



5. Functional neuroimaging biomarkers



6. PET biomarkers in psychiatry



7. Digital markers of mental health problems: phenotyping across biological, psychological and environmental dimensions



8. Staging biomarkers in psychiatry



9. Biomarkers of delirium and cognitive impairment



10. Fluid-based biomarkers of Alzheimer's disease



11. Neuroimaging biomarkers in Alzheimer's disease and related disorders



12. Biomarkers of cognitive decline and dementia in Down's syndrome



13. Biomarkers of schizophrenia



14. Biomarkers for bipolar disorder



15. Biomarkers in anxiety disorders



16. Biomarkers in obsessive-compulsive spectrum disorders



17. Sleep disorders: identifying biomarkers and clinical applications



18. Biomarkers in substance use disorders



19. Biomarkers of traumatic brain injury and related neuropsychiatric disorders



20. Biomarkers in psychiatry: conceptual and methodological challenges



21. Ethical issues related to biomarkers in psychiatry



 

 

Antonio L Teixeira is Professor of Psychiatry and Neurology at the University of Texas Health Science Center at Houston. He also a professorial appointment at the Institute of Education and Research Santa Casa BH, Belo Horizonte, Brazil. Dr. Teixeira did medical training in psychiatry, internal medicine and neurology, also training in cellular biology and immunology. Besides investigating the role of immune mechanism in the pathophysiology of cognitive and behavioral symptoms, he has investigated fluid-based biomarkers in different neuropsychiatric conditions. He has edited several books, including 'Immunopsychiatry' (Oxford University Press, 2019), 'Perinatal inflammation and adult psychopathology (Springer, 2020). 

Natalia P Rocha is an Assistant Professor at the Mitchell Center for Alzheimer's Disease & Brain Disorders, Department of Neurology, University of Texas Health Science Center at Houston. Dr. Rocha is a Pharmacist with training in basic and translational neuroscience, especially in the field of Neuroimmunology. In addition to studying neuroimmunology/inflammation associated with neurodegeneration, Dr. Rocha has dedicated herself to investigating biological and neuroimaging markers related to neuropsychiatric disorders.

Michael Berk is the Alfred Deakin Professor of Psychiatry, School of Medicine, Deakin University, Director of the IMPACT Strategic Research Centre at the same institution, and Honorary Professorial Fellow at Melbourne University and Monash University. Dr. Berk 's major interests are in the discovery and implementation of novel therapies and risk factors and prevention of psychiatric disorders, especially mood disorders. Dr. Berk is a world-renowned psychiatrist, with major contributions to the field and an impressive track of original publications.